- Home
- VOR vs SRL Comparison
VOR vs SRL Comparison
Compare VOR & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- SRL
- Stock Information
- Founded
- VOR 2015
- SRL 2017
- Country
- VOR United States
- SRL China
- Employees
- VOR N/A
- SRL N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- SRL Professional Services
- Sector
- VOR Health Care
- SRL Consumer Discretionary
- Exchange
- VOR Nasdaq
- SRL Nasdaq
- Market Cap
- VOR 134.8M
- SRL 115.0M
- IPO Year
- VOR 2021
- SRL N/A
- Fundamental
- Price
- VOR $0.72
- SRL $8.11
- Analyst Decision
- VOR Strong Buy
- SRL
- Analyst Count
- VOR 7
- SRL 0
- Target Price
- VOR $9.43
- SRL N/A
- AVG Volume (30 Days)
- VOR 269.5K
- SRL 4.1K
- Earning Date
- VOR 03-20-2025
- SRL 04-28-2025
- Dividend Yield
- VOR N/A
- SRL 3.25%
- EPS Growth
- VOR N/A
- SRL N/A
- EPS
- VOR N/A
- SRL N/A
- Revenue
- VOR N/A
- SRL $33,997,735.00
- Revenue This Year
- VOR N/A
- SRL N/A
- Revenue Next Year
- VOR N/A
- SRL N/A
- P/E Ratio
- VOR N/A
- SRL N/A
- Revenue Growth
- VOR N/A
- SRL N/A
- 52 Week Low
- VOR $0.63
- SRL $5.74
- 52 Week High
- VOR $2.43
- SRL $9.99
- Technical
- Relative Strength Index (RSI)
- VOR 28.48
- SRL 56.25
- Support Level
- VOR $0.75
- SRL $7.82
- Resistance Level
- VOR $0.93
- SRL $8.16
- Average True Range (ATR)
- VOR 0.07
- SRL 0.19
- MACD
- VOR 0.00
- SRL 0.02
- Stochastic Oscillator
- VOR 7.61
- SRL 74.74
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.